[Melanoderma appearing after a long administration of Myleran in 3 patients with chronic myeloid leukemia].
D002066:Busulfan / Q000633:toxicity*; D007938:Leukemia; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D007951:Leukemia, Myeloid / Q000628:therapy*; D008548:Melanosis / Q000209:etiology*
D002066:Busulfan
BUSULFAN/toxicology; LEUKEMIA, MYELOCYTIC/therapy; MELANOSIS/etiology